# OnCo record paper-yau-rcb-pooled-analysis-5161-lancet-oncol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-yau-rcb-pooled-analysis-5161-lancet-oncol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-yau-rcb-pooled-analysis-5161-lancet-oncol-2022" ;
  schema:name "Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients"@en ;
  schema:description "A pooled analysis of 5,161 patients from 12 European and US institutions and trials confirming that the residual cancer burden score predicts relapse in every breast cancer subtype, and proposing it become part of standard pathology reporting after pre-surgery chemotherapy."@en ;
  schema:url <https://onco.cc/key-papers/paper-yau-rcb-pooled-analysis-5161-lancet-oncol-2022/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(21)00589-1>, <https://pubmed.ncbi.nlm.nih.gov/34902335/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(21)00589-1> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Yau C, Osdoit M, van der Noordaa M, et al." ;
  onco:related <https://onco.cc/key-papers/paper-symmans-rcb-long-term-prognosis-subtype-jco-2017/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/rcb/>, <https://onco.cc/terms/efs/>, <https://onco.cc/terms/hazard-ratio/> ;
  onco:journals <https://onco.cc/journals/lancet-oncology/> .